Showing 6991-7000 of 9139 results for "".
- Arena Completes Full Enrollment of Etrasimod Phase 2 ADVISE Trial for ADhttps://practicaldermatology.com/news/arena-completes-full-enrollment-of-etrasimod-phase-2-advise-trial-for-ad/2460403/
- NEA Announces 2020 Eczema Research Grant Cycle Openinghttps://practicaldermatology.com/news/nea-announces-2020-eczema-research-grant-cycle-opening/2460387/The
- Calling All Heroes: Cutera Seeks to Honor COVID-19 Championshttps://practicaldermatology.com/news/calling-all-heroes-cutera-seeks-to-honor-covid-19-champions/2460380/From physicians going back to the ER and conducting hospital rounds to supporting food depositories and shelters, to doctors donating personal protective equipment, ventilators, and office facilities as needed during the COVID-19 global pandemic, Cutera wants to shine a spotlight on its customers
- COVID-19 By the Numbers: April 28 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-april-28-edition/2460365/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- MD Survey: Telehealth Booming, Prescribing Habits Changing During Pandemichttps://practicaldermatology.com/news/md-survey-telehealth-booming-prescribing-habits-changing-during-pandemic/2460360/More than four-fifths of physicians saw fewer patients in late March, averaging 40 patients per week vs. 103 per week prior to March 2020, according to a new survey of 500 U.S physicians by AbelsonTaylor, a health and wellness marketing agency. What’s more, three-quarters of physi
- LEO Pharma Enters License Agreement with Oneness Biotech, Microbio Shanghai for Atopic Dermatitis and Asthma Drug Candidatehttps://practicaldermatology.com/news/leo-pharma-enters-license-agreement-with-oneness-biotech-microbio-shanghai-for-atopic-dermatitis-and-asthma-drug-candidate/2460353/
- Wontech Scores FDA Nod for Sandro Dual Laserhttps://practicaldermatology.com/news/wontech-scores-fda-nod-for-sandro-dual-laser/2460333/The U.S. Food and Drug Administration granted 510 (K) marketing clearance to Wontech’s Sandro Dual, a hybrid Nd:YAG & Alexandrite laser device. In the hybrid mode, by irradiating a short time difference between two wavelengths of 755nm and 1064nm, the laser accurately hits its
- Revian Awarded Patent for Biostimulatory Light Combinationshttps://practicaldermatology.com/news/revian-awarded-patent-for-biostimulatory-light-technology/2460249/Revian Inc. has received from the United States Patent and Trademark Office (USPTO) U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the u
- New Anti-Acne Launches from Ceravehttps://practicaldermatology.com/news/new-launches-from-cerave/2460236/CeraVe is rolling out
- NavaDerm Partners Adds Dan Wechsler as Executive Chairmanhttps://practicaldermatology.com/news/navaderm-partners-adds-dan-wechsler-as-executive-chairman/2460225/Dan Wechsler is the new Executive Chairman of NavaDerm Partners, a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm. Wechs